David Rigterink

CEO at Cytomos

David Rigterink's work experience includes:

- Current CEO role at Cytomos since 2022.

- Biotech Specialist Asia & EMEA (SUS Freeze/Transport & Thaw Technologies) at Pall Corporation from November 2020 to September 2022.

- Business Development role at Single Use Support GmbH from October 2019 to November 2020.

- Head of Sartorius Japan at Sartorius from October 2017 to September 2019.

- Director of Sales, Marketing & Service (Biopharma | Bioprocess & Lab) at SARTORIUS STEDIM JAPAN KK from November 2017 to July 2019.

- Director of Sales & Marketing, Biopharma (Bioprocess) at SARTORIUS STEDIM JAPAN KK in October 2017.

- Director of Bioprocess Solutions | Sales & Marketing North Europe at Sartorius Stedim Biotech from May 2011 to September 2017.

- Account Manager of Bioprocess Solutions | Sales West Germany at Sartorius Stedim Biotech from September 2008 to April 2011.

- Customer Support | Sales UK & IRE at Enya Ltd from July 2004 to December 2006.

David Rigterink completed their education with a Honours Degree of Bachelor of Arts in Business Administration, with a specialization in Strategic Management and Marketing, from the University of Portsmouth in 2008. Prior to that, they obtained a Diploma in Business Economics from LDT Nagold in 2007. David'seducational journey began at Gymnasium Nordhorn, where they completed their secondary education and obtained their Abitur in 2003. David'sstudies at Gymnasium Nordhorn focused on English, Biology, and History.

Links

Previous companies

Sartorius logo

Timeline

  • CEO

    January, 2022 - present